Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis

Synergistic Inhibition of Drug-Resistant Colon Cancer Growth with PI3K/mTOR Dual Inhibitor BEZ235 and Nano-Emulsioned Paclitaxel via Reducing Multidrug Resistance and Promoting Apoptosis

Yali Hu,1,2,* Kunpeng Zhang,1,* Xingyao Zhu,1,* Xiuyan Zheng,1 Chao Wang,1 Xiao Niu,1 Teng Jiang,1 Xinhua Ji,1 Weilin Zhao,1 Lijuan Pang,1 Yan Qi,1 Feng Li,1,3 Li Li,4 Zhiping Xu,4 Wenyi Gu,4 Hong Zou1 1Department of Pathology, The First Affiliated Hospital, School of Medicine, Shihezi University, K...

Full description

Bibliographic Details
Main Authors: Hu Y, Zhang K, Zhu X, Zheng X, Wang C, Niu X, Jiang T, Ji X, Zhao W, Pang L, Qi Y, Li F, Li L, Xu Z, Gu W, Zou H
Format: Article
Language:English
Published: Dove Medical Press 2021-03-01
Series:International Journal of Nanomedicine
Subjects:
colon cancer
nanoemulsion
paclitaxel
bez235
drug-resistance.
Online Access:https://www.dovepress.com/synergistic-inhibition-of-drug-resistant-colon-cancer-growth-with-pi3k-peer-reviewed-article-IJN

Internet

https://www.dovepress.com/synergistic-inhibition-of-drug-resistant-colon-cancer-growth-with-pi3k-peer-reviewed-article-IJN

Similar Items